In spite of initial skepticism, new advancements in peptide drug discovery have rejuvenated desire in peptides as therapeutic brokers, with about 70 peptides now marketed and a number of other Some others in clinical development.Clinical trials and preclinical studies are highlighted, displaying the efficacy of peptide vaccines in inducing an immun